{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:49:43Z","timestamp":1791110983864,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1006\/mgme.2000.3039","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T19:46:30Z","timestamp":1032378390000},"page":"225-232","source":"Crossref","is-referenced-by-count":53,"title":["Osteogenesis Imperfecta: Prospects for Molecular Therapeutics"],"prefix":"10.1006","volume":"71","author":[{"given":"Antonella","family":"Forlino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan C.","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/mgme.2000.3039_RF1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.bi.64.070195.002155","article-title":"Collagen: Molecular biology, diseases, and potentials for gene therapy","volume":"64","author":"Prockop","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"10.1006\/mgme.2000.3039_RF2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1096\/fasebj.9.15.8529832","article-title":"Protein motifs. The triple-helix motif in proteins","volume":"9","author":"Brodsky","year":"1995","journal-title":"FASEB J"},{"key":"10.1006\/mgme.2000.3039_RF3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.bb.20.060191.001033","article-title":"The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper","volume":"20","author":"Engel","year":"1991","journal-title":"Biophys Biophys Chem"},{"key":"10.1006\/mgme.2000.3039_RF4","series-title":"Connective Tissue and Heritable Disorders","first-page":"317","article-title":"Osteogenesis Imperfecta","author":"Byers","year":"1993"},{"key":"10.1006\/mgme.2000.3039_RF5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in Osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J Med Genet"},{"key":"10.1006\/mgme.2000.3039_RF6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.20.3.203","article-title":"Heterogeneity of Osteogenesis Imperfecta type I","volume":"20","author":"Paterson","year":"1983","journal-title":"J Med Genet"},{"key":"10.1006\/mgme.2000.3039_RF7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0140-6736(78)90108-3","article-title":"Classification of Osteogenesis Imperfecta by dental characteristics","volume":"1","author":"Levin","year":"1978","journal-title":"Lancet"},{"key":"10.1006\/mgme.2000.3039_RF8","first-page":"91","article-title":"Osteogenesis Imperfecta and hearing loss","volume":"50","author":"Verstreken","year":"1996","journal-title":"Acta Otorhinolaryngol Belg"},{"key":"10.1006\/mgme.2000.3039_RF9","first-page":"237","article-title":"Perinatal lethal Osteogenesis Imperfecta (OI Type II): A biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen","volume":"42","author":"Byers","year":"1988","journal-title":"Am J Hum Genet"},{"key":"10.1006\/mgme.2000.3039_RF10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1148\/radiology.136.2.7403509","article-title":"\u201cPopcorn\u201d ossifications: A prognostic sign in Osteogenesis Imperfecta","volume":"136","author":"Goldman","year":"1980","journal-title":"Radiology"},{"key":"10.1006\/mgme.2000.3039_RF11","series-title":"Schinz. Radiologische diagnostik in klinik und praxis","first-page":"728","article-title":"Osteogenesis Imperfecta","author":"Steinmann","year":"1991"},{"key":"10.1006\/mgme.2000.3039_RF12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajmg.1320450223","article-title":"Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfecta","volume":"45","author":"Marini","year":"1993","journal-title":"Am J Med Genet"},{"key":"10.1006\/mgme.2000.3039_RF13","first-page":"S389","article-title":"Type V Osteogenesis Imperfecta","volume":"12","author":"Glorieux","year":"1997","journal-title":"J Bone Min Res"},{"key":"10.1006\/mgme.2000.3039_RF14","first-page":"638","article-title":"Osteogenesis Imperfecta Type I: Molecular heterogeneity for COL1A1 null alleles of type I collagen","volume":"55","author":"Willing","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1006\/mgme.2000.3039_RF15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9","article-title":"Mutations in fibrillar collagens (Type I, II, III and XI), fibril-associated collagen (Type IX) and network-forming collagen (Type X) cause a spectrum of disease of bone, cartilage, and blood vessels","volume":"9","author":"Kuivaniemi","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1006\/mgme.2000.3039_RF16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.bb.20.060191.001033","article-title":"Folding of collagen triple helices and the effects of mutations that disrupt the zipper","volume":"20","author":"Engel","year":"1981","journal-title":"Annu Rev Biophys Chem"},{"key":"10.1006\/mgme.2000.3039_RF17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/bies.950030306","article-title":"The molecular genetics of collagen","volume":"3","author":"Sykes","year":"1985","journal-title":"Bioassay"},{"key":"10.1006\/mgme.2000.3039_RF18","first-page":"975","article-title":"Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogeneisis imperfecta","volume":"46","author":"Wenstrup","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1006\/mgme.2000.3039_RF19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jmg.28.7.433","article-title":"Osteogenesis Imperfecta: Translation of mutations to phenotype","volume":"28","author":"Byers","year":"1991","journal-title":"J Med Genet"},{"key":"10.1006\/mgme.2000.3039_RF20","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/S0021-9258(18)53826-6","article-title":"Serine for glycine substitution in type I collagen in two cases of type IV Osteogenesis Imperfecta (OI): Additional evidence for a regional model of OI pathophysiology","volume":"268","author":"Marini","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1006\/mgme.2000.3039_RF21","unstructured":"Marini, J, C, Forlino, A, Cabral, W, A, Relationship of genotype and OI phenotype for mutations in \u03b12(I): Update of the regional model. 7, th, International Conference on Osteogenesis Imperfecta O-10-O-10 1999. (Abstract)"},{"key":"10.1006\/mgme.2000.3039_RF22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/332131a0","article-title":"Perinatal lethal Osteogenesis Imperfecta in transgenic mice bearing an engineered mutant pro\u03b11(I) collagen gene","volume":"332","author":"Stacey","year":"1988","journal-title":"Nature"},{"key":"10.1006\/mgme.2000.3039_RF23","doi-asserted-by":"crossref","first-page":"23373","DOI":"10.1016\/S0021-9258(18)54506-3","article-title":"Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of Osteogenesis Imperfecta","volume":"266","author":"Khillan","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1006\/mgme.2000.3039_RF24","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.90.5.1701","article-title":"Defective pro\u03b12(I) collagen synthesis in a recessive mutation in mice: A model of human Osteogenesis Imperfecta","volume":"90","author":"Chipman","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/mgme.2000.3039_RF25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/304315a0","article-title":"Embryonic lethal mutation in mice induced by retrovirus insertion into the \u03b11(I) collagen gene","volume":"304","author":"Schnieke","year":"1983","journal-title":"Nature"},{"key":"10.1006\/mgme.2000.3039_RF26","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1073\/pnas.87.18.7145","article-title":"Transgenic mouse model of the mild dominant form of Osteogenesis Imperfecta","volume":"87","author":"Bonadio","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/mgme.2000.3039_RF27","doi-asserted-by":"crossref","first-page":"37923","DOI":"10.1074\/jbc.274.53.37923","article-title":"Use of the Cre\/lox recombination system to develop a non-lethal knock-in murine model for Osteogenesis Imperfecta with an \u03b11(I) G349C substitution. Variability in phenotype in BrtlIV mice","volume":"274","author":"Forlino","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1006\/mgme.2000.3039_RF28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/(SICI)1098-1004(1998)11:5<395::AID-HUMU7>3.0.CO;2-4","article-title":"Three novel type I collagen mutations in Osteogenesis Imperfecta type IV probands are associated with discrepancies between electrophoretic migration in osteoblast and fibroblast collagen","volume":"11","author":"Sarafova","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1006\/mgme.2000.3039_RF29","series-title":"Manipulating the Mouse Embryo. A Laboratory Manual","author":"Hogan","year":"1994"},{"key":"10.1006\/mgme.2000.3039_RF30","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","DOI":"10.1016\/0076-6879(93)25056-8","article-title":"Manipulation of transgenes by site-specific recombination: Use of Cre recombinase","author":"Sauer","year":"1993"},{"key":"10.1006\/mgme.2000.3039_RF31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/07357908909038283","article-title":"Gene therapy for genetic diseases","volume":"7","author":"Kohn","year":"1989","journal-title":"Cancer Invest"},{"key":"10.1006\/mgme.2000.3039_RF32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/07853899608999114","article-title":"Ribozymes: Structure, function and potential therapy for dominant genetic disorders","volume":"28","author":"Grassi","year":"1996","journal-title":"Ann Med"},{"key":"10.1006\/mgme.2000.3039_RF33","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1073\/pnas.91.14.6298","article-title":"Partial rescue of a lethal phenotype of fragile bones in transgenic mice with a chimeric antisense gene directed against a mutated collagen gene","volume":"91","author":"Khillan","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/mgme.2000.3039_RF34","doi-asserted-by":"crossref","first-page":"11032","DOI":"10.1021\/bi00202a024","article-title":"Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides. The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA","volume":"33","author":"Laptev","year":"1994","journal-title":"Biochemistry"},{"key":"10.1006\/mgme.2000.3039_RF35","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI118434","article-title":"Antisense oligodeoxynucleotydes selectively suppress expression of the mutant \u03b12(I) collagen allele in type IV Osteogenesis Imperfecta fibroblasts. A molecular approach to therapeutics of dominant negative disorders","volume":"97","author":"Wang","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1006\/mgme.2000.3039_RF36","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1093\/nar\/25.17.3451","article-title":"Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects","volume":"25","author":"Grassi","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.1006\/mgme.2000.3039_RF37","doi-asserted-by":"crossref","first-page":"9537","DOI":"10.1089\/oli.1.1999.9.537","article-title":"A mutation-independent therapeutic strategem for Osteogenesis Imperfecta","volume":"9","author":"Millington-Ward","year":"1999","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"10.1006\/mgme.2000.3039_RF38","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1651-2227.1997.tb08573.x","article-title":"Parental mosaicism and autosomal dominant mutations causing structural abnormalities of collagen type I are frequent in families with Osteogenesis Imperfecta","volume":"86","author":"Lund","year":"1997","journal-title":"Acta Paediatr"},{"key":"10.1006\/mgme.2000.3039_RF39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01991915","article-title":"Genetic Counselling on brittle grounds: Recurring Osteogenesis Imperfecta due to parental mosaicism for a dominant mutation","volume":"154","author":"Raghunath","year":"1995","journal-title":"Eur J Pediatr"},{"key":"10.1006\/mgme.2000.3039_RF40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ajmg.1320450218","article-title":"Somatic cell mosaicism another source of phenotypic heterogeneity in nuclear families with Osteogenesis Imperfecta","volume":"45","author":"Costantinou-Deltas","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1006\/mgme.2000.3039_RF41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.276.5309.71","article-title":"Marrow stromal cells as stem cells for nonhematopoietic tissues","volume":"276","author":"Prockop","year":"1997","journal-title":"Science"},{"key":"10.1006\/mgme.2000.3039_RF42","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1073\/pnas.92.11.4857","article-title":"Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice","volume":"92","author":"Pereira","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/mgme.2000.3039_RF43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nature Med"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719200930397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719200930397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T02:07:34Z","timestamp":1620007654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719200930397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":43,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S1096719200930397"],"URL":"https:\/\/doi.org\/10.1006\/mgme.2000.3039","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}